Clinical Trial: Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title:

Brief Summary: The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to recurrent laryngeal cancer.

Detailed Summary:

By enrolling patients with recurrent laryngeal cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and natural killer (NK) cells.

The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).


Sponsor: Fuda Cancer Hospital, Guangzhou

Current Primary Outcome: Relief degree of tumors [ Time Frame: 3 months ]

It will be evaluated by the Response Evaluation Criteria in Solid Tumors（RECIST）


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Progress free survival（PFS） [ Time Frame: 1 year ]
  • Overall survival（OS） [ Time Frame: 3 years ]


Original Secondary Outcome: Same as current

Information By: Fuda Cancer Hospital, Guangzhou

Dates:
Date Received: July 27, 2016
Date Started: July 2016
Date Completion: July 2019
Last Updated: July 27, 2016
Last Verified: July 2016